Debevoise & Plimpton LLP has advised agilon health (NYSE: AGL) and Clayton, Dubilier & Rice in the transaction. The transaction consiste in the secondary offering of...
Agilon Health’s $2 Billion Secondary Offering and Repurchase of Common Stock
Agilon Health’s $1.2 Billion Initial Public Offering
Debevoise & Plimpton LLP advised agilon health, inc. In the transaction, while Cravath represented the underwriters. agilon health, inc. (NYSE: AGL) closed its initial public offering of 53,590,000...